OmniAb (OABI) Non Operating Income (2022 - 2026)
OmniAb's (OABI) quarterly Non Operating Income came in at $564000.0 in Q1 2026, up 4.83% year-on-year from $538000.0 in Q1 2025, and down 53.77% on a QoQ basis from $1.2 million in Q4 2025.
OmniAb (OABI) Non Operating Income (2022 - 2026) Analysis & Trends
OmniAb (OABI) has 5 years of Non Operating Income data on file, last reported at $564000.0 in Q1 2026.
- On a quarterly basis, Non Operating Income rose 4.83% year-over-year to $564000.0 in Q1 2026; TTM through Mar 2026 was $2.7 million, a 1.77% increase from a year earlier, with the FY2025 full-year figure at $2.7 million, down 13.46% from the prior year.
- Non Operating Income for Q1 2026 stood at $564000.0, down from $1.2 million in the prior quarter.
- Over the last five years, Non Operating Income for OABI reached as high as $1.3 million in Q1 2023 and fell as low as $454000.0 in Q3 2025.
- Historically, Non Operating Income has averaged $855214.3 across 5 years, with a median of $729500.0 in 2024.
- Across the five-year window, Non Operating Income soared 100.68% in 2023 and slumped 46.35% in 2024, its largest moves.
- Year by year, Non Operating Income stood at $587000.0 in 2022, then surged by 100.68% to $1.2 million in 2023, then plunged by 44.23% to $657000.0 in 2024, then jumped by 85.69% to $1.2 million in 2025, then sank by 53.77% to $564000.0 in 2026.
- Per Business Quant data, the three most recent Non Operating Income figures were $564000.0 in Q1 2026, $1.2 million in Q4 2025, and $454000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -8.59 Mn |
| 10 | OmniAb | 263.54 Mn | 214.47 Mn | 14.41 Mn | 564,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 564,000.00 |
| Dec 31, 2025 | 1.22 Mn |
| Sep 30, 2025 | 454,000.00 |
| Jun 30, 2025 | 463,000.00 |
| Mar 31, 2025 | 538,000.00 |
| Dec 31, 2024 | 657,000.00 |
| Sep 30, 2024 | 683,000.00 |
| Jun 30, 2024 | 776,000.00 |
| Mar 31, 2024 | 975,000.00 |
| Dec 31, 2023 | 1.18 Mn |
| Sep 30, 2023 | 1.27 Mn |
| Jun 30, 2023 | 1.28 Mn |
| Mar 31, 2023 | 1.32 Mn |
| Dec 31, 2022 | 587,000.00 |